Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995 -: Comparison of HIV-associated cases to other immunocompromised states

被引:212
作者
Mansharamani, NG
Garland, R
Delaney, D
Koziel, H
机构
[1] Beth Israel Deaconess Med Ctr, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
AIDS; HIV; immunosuppression; mechanical ventilation; mortality; Pneumocystic carinii pneumonia;
D O I
10.1378/chest.118.3.704
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Encompassing periods preceding and following major advances in the diagnosis and management of HIV-related Pneumocystis carinii pneumonia (PCP), the purpose of this study was to determine whether management and outcome patterns of non-HIV PCP parallel the management and outcomes of AIDS-related PCP. Design: Retrospective review of medical records. Setting: A 375-bed tertiary-care urban teaching hospital and referral center. Patients: All adult patients with morphologically confirmed PCP from 1985 to 1995. Measurements and results: From 1985 to 1995, 638 confirmed cases of PCP were identified, including 605 cases in 442 HIV-positive persons (HIV + PCP), and 33 cases in 33 non-HIV patients (non-HIV PCP). For HIV + PCP cases, a peak of 104 cases occurred in 1987, with a gradual decline to 23 in 1995. The proportion of cases requiring hospitalization declined from a peak of 91.6% in 1987 to a low of 51.6% in 1992. ICU admission was required for 6.3 to 8.2%, and mechanical ventilation for 4.7 to 5.7%. Overall mortality improved from 11.7 to 6.6%, although mortality for intubated patients remained at 50 to 60%. For the non-HIV PCP cases, 97% occurred from 1989 to 1995 with similar annual frequency, 97% required hospitalization, 69% required ICU admission, and 66% required intubation. Overall mortality was 39%, and mortality for intubated patients was 59%. Conclusions: Despite major advances in diagnosis and management, PCP remains a significant problem in non-HIV-infected patients, and respiratory failure remains associated with a high mortality rate for patients with bot HIV + PCP and non-HIV PCP.
引用
收藏
页码:704 / 711
页数:8
相关论文
共 46 条
[1]   PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITHOUT AIDS, 1980 THROUGH 1993 - AN ANALYSIS OF 78 CASES [J].
AREND, SM ;
KROON, FP ;
VANTWOUT, JW .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (22) :2436-2441
[2]   A CONTROLLED TRIAL OF EARLY ADJUNCTIVE TREATMENT WITH CORTICOSTEROIDS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BOZZETTE, SA ;
SATTLER, FR ;
CHIU, J ;
WU, AW ;
GLUCKSTEIN, D ;
KEMPER, C ;
BARTOK, A ;
NIOSI, J ;
ABRAMSON, I ;
COFFMAN, J ;
HUGHLETT, C ;
LOYA, R ;
CASSENS, B ;
AKIL, B ;
MENG, TC ;
BOYLEN, CT ;
NIELSEN, D ;
RICHMAN, DD ;
TILLES, JG ;
LEEDOM, J ;
MCCUTCHAN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1451-1457
[3]   PNEUMOCYSTIS-CARINII INFECTION [J].
BURKE, BA ;
GOOD, RA .
MEDICINE, 1973, 52 (01) :23-51
[4]  
CDC (Cent. Dis. Control Prev.), 1992, MMWR RECOMM REP, V41, P1
[5]   CHANGES IN HOSPITAL ADMISSIONS PATTERN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE ERA OF PNEUMOCYSTIS-CARINII PROPHYLAXIS [J].
CHIEN, SM ;
RAWJI, M ;
MINTZ, S ;
RACHLIS, A ;
CHAN, CK .
CHEST, 1992, 102 (04) :1035-1039
[6]   FOLLOW-UP BRONCHOALVEOLAR LAVAGE IN AIDS PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA - PNEUMOCYSTIS-CARINII BURDEN PREDICTS EARLY RELAPSE [J].
COLANGELO, G ;
BAUGHMAN, RP ;
DOHN, MN ;
FRAME, PT .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (05) :1067-1071
[7]   CHANGING USE OF INTENSIVE-CARE FOR HIV-INFECTED PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA [J].
CURTIS, JR ;
GREENBERG, DL ;
HUDSON, LD ;
FISHER, LD ;
KRONE, MR ;
COLLIER, AC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :1305-1310
[8]   EQUAL SURVIVAL RATES FOR 1ST, 2ND, AND 3RD EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
DOHN, MN ;
BAUGHMAN, RP ;
VIGDORTH, EM ;
FRAME, DL .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (12) :2465-2470
[9]   ORAL ATOVAQUONE COMPARED WITH INTRAVENOUS PENTAMIDINE FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS [J].
DOHN, MN ;
WEINBERG, WG ;
TORRES, RA ;
FOLLANSBEE, SE ;
CALDWELL, PT ;
SCOTT, JD ;
GATHE, JC ;
HAGHIGHAT, DP ;
SAMPSON, JH ;
SPOTKOV, J ;
DERESINSKI, SC ;
MEYER, RD ;
LANCASTER, DJ ;
FRAME, PT ;
MOHSENIFAR, Z ;
BUCKLEY, RM ;
CHEUNG, T ;
HYLAND, R ;
CHAN, C ;
LANG, W ;
MILDVAN, D ;
GREENBERG, SB ;
CRAVEN, D ;
HIRSCH, M ;
ELSADR, W ;
JOSEPH, P ;
HARDY, D ;
BROWN, N ;
ROGERS, M .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (03) :174-180
[10]   ACQUIRED IMMUNODEFICIENCY SYNDROME - EPIDEMIOLOGIC, CLINICAL, IMMUNOLOGICAL, AND THERAPEUTIC CONSIDERATIONS [J].
FAUCI, AS ;
MACHER, AM ;
LONGO, DL ;
LANE, HC ;
ROOK, AH ;
MASUR, H ;
GELMANN, EP .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) :92-106